Photo source: France24
Days after a panel of experts advised the use of the products in areas where strains of the coronavirus are circulating, the United Nations health agency identified the COVID-19 vaccine developed by the University of Oxford and drugmaker AstraZeneca for emergency use.
On Monday, a statement by the World Health Organization (WHO) said the relatively inexpensive shot developed by AstraZeneca-SKBio (South Korea) and the Serum Institute of India had been approved.
Tedros Adhanom Ghebreyesus, WHO director-general said that they are now ready for the rapid distribution of vaccines, But still got to proportion production.
He also added that the COVID-19 vaccine developers have to submit their dossiers to WHO. They have to do so for review at an equivalent time as they submit them to regulators in high-income countries.
Data source: Al Jazeera
Nigeria’s leading music figure and vocalist, Cobhams Asuquo, known for his singing and production said…
Following a mixed reaction from the South African community representatives, Khoi and San, the Cape…
Mitigating the process and service barriers in African rail transportation, the digital disruption has transformed…
Kais Saied, the Tunisian president has said in his speech that he will allow the…
You know the credibility of an ingredient when it’s plastered all over bottles and jars…
Cyclone Gombe that flooded large areas of central and northern Mozambique is consistently leading to…
This website uses cookies.